Skip to main content

New Approaches to Record and Integrate Cancer PROMs and PREMs Phase 2 Projects

Two projects from Phase 1 were awarded further funding of up to £100k each to undertake a 6 month development and evaluation of a proof of concept/prototype starting from 5 February 2018. 

Px HealthCare

OWise for Scotland: Embedding the mobile app platform demonstrated to improve patient experience and oncology outcomes in a NHS Scotland ecosystem

To increase patients’ quality of life, to improve clinical outcomes and to make cancer care more affordable, we need to accurately understand how cancer patients experience treatments. Px HealthCare (also called Px, which stands for Patient Experience) has developed the freely available app OWise, an independently validated, mobile platform supporting cancer patients during treatment. It was recently listed in the Top 25 of all health apps, OWise is a real game-changer as

  • its award-winning app was shown to improve both patient experience and the patient-doctor interaction,
  • while the fully anonymised, real-time Patient-Reported Outcome (PRO) data are collected and investigated using advanced data analytics to improve oncology outcomes.

This innovative project is aimed at bridging the gap between cancer patients and their healthcare providers by implementing a new prototype of the OWise platform enabling Scottish cancer patients to share real-time PRO data with healthcare providers and the clinical information system of their NHS hospital. This may have an immediate impact on how patients perceive their treatment, the management of side effects and symptoms and on personal outcomes. This novel extension of the OWise platform provides an excellent fit with Scotland’s Cancer Strategy, where person-centred care plays a key role in providing patients with optimal treatment. On a larger scale, the insights into real-world PRO data may contribute to better spending of the NHS budget and facilitate policymaking.

www.owise.uk
www.pxhealthcare.com

 

My Clinical Outcomes

My Clinical Outcomes: Cancer PROMs

My Clinical Outcomes (MCO) is a web-based platform for collecting and using Patient Reported Outcome Measures (PROMs) in clinical care.

MCO is embedded around existing clinical pathways and allows patients to regularly submit outcomes data throughout treatment and follow-up. Results are available in real-time to help healthcare professionals to monitor clinical progress and make more informed decisions, including prioritising face-to-face reviews for those most in need. Hospitals can use the aggregate data and analytics to understand variation in outcomes and to help improve overall quality and reduce ineffective activity.

MCO has been in use in various clinical specialties in the NHS and private sector since 2011. The Cancer Innovation Challenge project provides the opportunity to work with NHS Scotland to design enhancements tailored to the specific needs of cancer patients in Scotland. This will include a mobile application that draws on existing functionality but that has dashboards and content tailored to feedback from local patient groups. MCO will work with NHS Ayrshire and Arran to deliver a PROMs solution for use in clinical practice, and also with Orion Health to integrate into the Clinical Portal that is in use across Scotland.

We are at tipping point where internet availability and patient expectations are for the first time making it possible to use digital tools to help deliver better patient outcomes. MCO is very excited to have the opportunity to play a part in helping make this important step forward for cancer patients in Scotland.

www.myclinicaloutcomes.com

Recent Tweets

Cancer Challenge (Yesterday)
RT @CRUKEastScot: Exciting announcement: Edinburgh has been named as a Centre of Excellence in Brain Tumour Research with a further £1.5M a…
Cancer Challenge (Yesterday)
RT @DataLabScotland: Major Barriers to Useful Risk Prediction Must Be Overcome to Reach the Full Potential of #BigData - via Medical Bag:…

©2018 Cancer Innovation Challenge | Privacy and Cookie Policy | Terms of Use